FinCanna Reports Strong Customer Demand for Portfolio Company QVI Inc., a Multi Brand Cannabis Manufacturer in Sonoma County, California
QVI’s Facility is Designed for Annual Operating Capacity of ~US$45 Million
FinCanna Capital Corp. (“FinCanna”) (CSE:CALI)(OTCQB:FNNZF), a royalty company for the U.S. licensed cannabis industry is pleased to announce growing demand for manufacturing services for its investee company QVI, Inc. doing business as “The Galley”, a cannabis infused product manufacturer located in Sonoma County, California
QVI’s 8,300 sq. ft. state of the art co-manufacturing facility located in Santa Rosa, CA, is built to FDA and CDPH standards and has been fully operational since July 2020. The company is experiencing accelerating demand for its services from a growing roster of over 30 in-state and out-of-state highly regarded consumer brands. QVI is also experiencing a steady increase in re-orders from existing clients that is establishing an increasing base of recurring monthly revenues.
QVI management attributes the acceleration of customer demand to its automated manufacturing expertise, superior production quality and its “one stop shop” capability to produce virtually all high-value cannabis products, including Edibles, Topicals, Tinctures, Chocolate, Hard Candies, Gummies and Beverages under one roof. Additionally, its outstanding R&D team has the ability to assist brands in launching not only new individual products but whole new product lines. The Galley’s operational design also positions the business to rapidly scale production as demand escalates towards its annual operating capacity of approximately US$45 million. For more information about “The Galley” please visit www.thegalleysr.com
Annie Holman, CEO of QVI Inc. stated, “We are extremely pleased with our growing roster of client Brands which is a testament to our multi-talented production team’s ability to consistently deliver the very best quality in the market. The word is getting out. The Galley is being increasingly recognized as “the” manufacturing solution for in and out-of-state Brands who recognize that in a competitive marketplace, only the “best” will do.”
Andriyko Herchak, CEO of FinCanna Capital said, “We’re very happy with QVI’s growing roster of great brands and the continued increase of monthly re-orders from these customers. This accelerating growth clearly demonstrates the abilities of QVI’s outstanding team led by CEO Annie Holman and their growing reputation across the industry for excellence. We are anticipating a breakthrough year for QVI and look forward to sharing in their success with an increasing monthly royalty income stream for our shareholders.”
QVI’s immediate goal is to become the premier contract cannabis manufacturer in California, the largest single market in North America and, upon success, to license products nationally and globally.
The legal U.S. cannabis market is expected to reach more than US$41 billion in annual sales by 2025 with California, the single largest market in North America, representing an estimated 20% market share or US$8.2 billion. (New Frontier Data)
About FinCanna Capital Corp.
FinCanna is a royalty company that provides growth capital to rapidly emerging private companies operating in the licensed U.S cannabis industry. The company earns its revenue from royalties paid by its investee companies that are calculated based on a percentage their total revenues.
FinCanna’s scalable royalty model provides an attractive alternative or complement to debt or equity financing for its investee companies. FinCanna is focused on delivering high-impact returns to its shareholders by way of a strategically diversified investment portfolio.
FinCanna Capital Corp.
Andriyko Herchak, CEO & Director
Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All forward looking statements, other than statements of historical fact, included herein include but are not limited to the statements relating to the effectiveness of QVI’s products or services, the ability of QVI to continue and expand operations and the timing thereof, the success of sales and other marketing plans, the size, expected capacity, success of operations and future revenues and timing thereof, QVI’s ability to obtain financing for the development of its business and its ability to pay FinCanna royalties or other amounts when due. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the CSE listing statement available at www.SEDAR.com and other reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the respective companies undertake no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements.
SOURCE: FinCanna Capital Corp.
View source version on accesswire.com:
News Provided by ACCESSWIRE via QuoteMedia
FinCanna Capital Corp.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact firstname.lastname@example.org, or